BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8935860)

  • 1. [The role of cancer registries in the evaluation of breast cancer screening].
    Schaffer P; Renaud R; Gairard B; Guldenfels C
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S15-21. PubMed ID: 8935860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
    Séradour B; Allemand H; Schaffer P
    Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Population screening for breast cancer: an interim assessment].
    van der Maas PJ
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1096-9. PubMed ID: 10876703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options.
    Becker N; Hakama M; Nyström L
    Eur J Cancer Prev; 2007 Jun; 16(3):225-31. PubMed ID: 17415093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Using medical imaging for a comprehensive breast cancer screening program].
    Dilhuydy MH
    Bull Cancer; 2009 Nov; 96(11):1071-86. PubMed ID: 19887333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of mass screening for breast cancer in the Somme district (France) between 1990 and 1996].
    Ganry O; Peng J; Dubreuil A
    Rev Epidemiol Sante Publique; 1999 Sep; 47(4):335-41. PubMed ID: 10519174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of service screening for breast cancer by clinical breast examination using regional cancer registry data].
    Sibata A; Takahashi T; Ouchi N; Fukao A
    Nihon Koshu Eisei Zasshi; 2005 Feb; 52(2):128-36. PubMed ID: 15791899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation of breast cancer tumour stage and the degree of registration in a population-based cancer registry].
    Katalinic A; Holzmann M; Kunze U
    Gesundheitswesen; 2003; 65(8-9):509-15. PubMed ID: 14505270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast cancer screening: ethical problems. The Strasbourg experiment. Deontological issues raised by breast cancer screening: quality assurance and accreditation of structures].
    Haehnel P
    Bull Acad Natl Med; 1998; 182(8):1635-45; discussion 1646. PubMed ID: 10188309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
    van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in mass screening of breast cancer with mammography in France].
    Mamelle N; Lacour A; Anes A; Bazin B; Chaperon J; Duru G; Piette C; San Marco JL; Schaffer P; Arnold F
    Rev Epidemiol Sante Publique; 1994; 42(1):34-49. PubMed ID: 8134664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cost of breast cancer screening in France].
    Wait S; Schaffer P; Séradour B; Guldenfels C; Gairard B; Morin F; Piana L
    J Radiol; 2000 Jul; 81(7):799-806. PubMed ID: 10915994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign].
    Fender M; Schaffer P; Dellenbach P
    Sante Publique; 2000 May; 12 Spec No():11-20. PubMed ID: 10989625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Female genital and breast cancers in France: geographic distribution and estimation of incidence].
    Chaplain G; Grosclaude P; Arveux P; Raverdy N; Menegoz F; Henry-Amar M; Schaffer P; Daures JP; de Vathaire F
    Bull Cancer; 1997 Oct; 84(10):935-40. PubMed ID: 9435794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should the general population be screened for breast cancer?].
    Schaffer P
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(8):750-4. PubMed ID: 9509314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.